Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
230.1 USD | -2.21% | +0.09% | -2.67% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.67% | 12.08B | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
+30.23% | 11.98B | |
+20.99% | 11.58B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Stephens Adjusts Charles River Laboratories International's PT to $280 From $270, Keeps Overweight Rating